A UK-led international study has identified steps that can be taken to improve the quality of MRI scans for prostate cancer screening. Research, published in Radiology, found "relatively simple and ...

Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new research. The REIMAGINE study, published today in ...

Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

Biparametric MRI, which omits the dynamic contrast enhancement sequence, can detect clinically significant prostate cancer as well as multiparametric MRI. Biparametric MRI performs as well as ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...

Global map of countries (n = 17) and the number of scanners (n = 64) that took part in phase II of the Global Variation in Magnetic Resonance Imaging Qualtiy of the Prostate (GLIMPSE) study. UK = ...

International experts have recommended quick and targeted MRI scans for prostate cancer screening. Some 21 urologists, radiologists and pathologists from Europe and the US agreed an "expert consensus ...

A new study has highlighted a significant knowledge gap among patients about repeat radiotherapy (reirradiation) as a treatment option for recurrent prostate cancer ...

The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 ...